L. Jønson

发表

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS genetics.

Identification of six new susceptibility loci for invasive epithelial ovarian cancer

Yurii B. Shvetsov, Simon G. Coetzee, A. Whittemore, 2015, Nature Genetics.

Splicing analysis of 14 BRCA1 missense variants classifies nine variants as pathogenic

T. Hansen, F. Nielsen, L. Jønson, 2015, Breast Cancer Research and Treatment.

Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations

F. Nielsen, A. Gerdes, T. V. Hansen, 2015, Familial Cancer.

Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction.

Mads Thomassen, Etienne Rouleau, Dieter Niederacher, 2010, Cancer research.

RNA‐binding IMPs promote cell adhesion and invadopodia formation

F. Nielsen, T. V. Hansen, J. Christiansen, 2006, The EMBO journal.

Enhanced peptide secretion by gene disruption of CYM1, a novel protease in Saccharomyces cerevisiae.

J. Rehfeld, A. Johnsen, L. Jønson, 2004, European journal of biochemistry.

Next‐generation sequencing: proof of concept for antenatal prediction of the fetal Kell blood group phenotype from cell‐free fetal DNA in maternal plasma

N. Tommerup, M. Bak, M. Hedegaard, 2013, Transfusion.

Characterization of BRCA1 and BRCA2 splicing variants: a collaborative report by ENIGMA consortium members

A. Spurdle, C. Lázaro, S. Tognazzo, 2012, Breast Cancer Research and Treatment.

Isolation of RNP granules.

F. Nielsen, J. Christiansen, L. Jønson, 2011, Methods in molecular biology.

Identification of a Danish breast/ovarian cancer family double heterozygote for BRCA1 and BRCA2 mutations

T. Hansen, F. Nielsen, A. Gerdes, 2010, Familial Cancer.

Identification of six pathogenic RAD51C mutations via mutational screening of 1228 Danish individuals with increased risk of hereditary breast and/or ovarian cancer

F. Nielsen, A. Gerdes, B. Ejlertsen, 2016, Breast Cancer Research and Treatment.

Whole-exome sequencing and genome-wide methylation analyses identify novel disease associated mutations and methylation patterns in idiopathic hypereosinophilic syndrome

L. Kristensen, Helene Myrtue Nielsen, K. Grønbæk, 2015, Oncotarget.

Concordance of Mutation Detection in Circulating Tumor DNA in Early Clinical Trials Using Different Blood Collection Protocols.

F. Nielsen, L. Jønson, U. Lassen, 2017, Clinical Laboratory.

Malignant T cells express lymphotoxin α and drive endothelial activation in cutaneous T cell lymphoma

C. Geisler, M. Wasik, A. Woetmann, 2015, Oncotarget.

Characterization of MYG1 gene and protein: subcellular distribution and function

J. Rehfeld, S. Kõks, E. Vasar, 2009, Biology of the cell.

Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

L. Olsen, Kristoffer Vitting-Seerup, H. Poulsen, 2017, BMC Cancer.

P08.06 Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patients

L. Olsen, Kristoffer Vitting-Seerup, H. Poulsen, 2016 .

Universitet IMP 3 RNP safe houses prevent miRNA-directed HMGA 2 mRNA decay in cancer and development

T. Hansen, F. Nielsen, Yohei Yamamoto, 2018 .

IMP3 RNP safe houses prevent miRNA-directed HMGA2 mRNA decay in cancer and development.

T. Hansen, F. Nielsen, Yohei Yamamoto, 2014, Cell reports.

Molecular profiling of tumour budding implicates TGFβ‐mediated epithelial–mesenchymal transition as a therapeutic target in oral squamous cell carcinoma

C. von Buchwald, F. Nielsen, L. Specht, 2015, The Journal of pathology.

Molecular Composition of IMP1 Ribonucleoprotein Granules*S

A. Krogh, L. Nielsen, T. Hansen, 2007, Molecular & Cellular Proteomics.

Identification of a novel BRCA1 nucleotide 4803delCC/c.4684delCC mutation and a nucleotide 249T>A/c.130T>A (p.Cys44Ser) mutation in two Greenlandic Inuit families: implications for genetic screening of Greenlandic Inuit families with high risk for breast and/or ovarian cancer

A. Albrechtsen, T. Hansen, F. Nielsen, 2010, Breast Cancer Research and Treatment.

Screening of 1331 Danish breast and/or ovarian cancer families identified 40 novel BRCA1 and BRCA2 mutations

T. Hansen, F. Nielsen, M. Andersen, 2011, Familial Cancer.

Genome‐wide identification of genes required for growth of Saccharomyces cerevisiae under ethanol stress

L. Jønson, A. Brandt, M. Kielland-Brandt, 2006, Yeast.

Germline Chromothripsis Driven by L1‐Mediated Retrotransposition and Alu/Alu Homologous Recombination

Z. Tümer, N. Tommerup, M. Bak, 2016, Human mutation.

Identification of a breast cancer family double heterozygote for RAD51C and BRCA2 gene mutations

F. Nielsen, A. Gerdes, T. V. Hansen, 2015, Familial Cancer.

Functional characterization of BRCA1 gene variants by mini-gene splicing assay

T. Hansen, F. Nielsen, A. Gerdes, 2014, European Journal of Human Genetics.

COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration

Peter Kraft, Mads Thomassen, Daniel J. Park, 2013, Breast Cancer Research.

Personalized oncology: genomic screening in phase 1

F. Nielsen, E. Santoni-Rugiu, L. Jønson, 2014, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-Cell lymphoma

D. Sasseville, C. Geisler, N. Mongan, 2015, Oncotarget.

Identification and distribution of CCK-related peptides and mRNAs in the rainbow trout, Oncorhynchus mykiss.

A. Johnsen, L. Jønson, I. Rourke, 2001, Biochimica et biophysica acta.

Elasmobranchs express separate cholecystokinin and gastrin genes.

J. Rehfeld, A. Johnsen, L. Jønson, 1997, Proceedings of the National Academy of Sciences of the United States of America.

A common Greenlandic Inuit BRCA1 RING domain founder mutation

A. Albrechtsen, P. Bjerregaard, T. Hansen, 2009, Breast Cancer Research and Treatment.

Identification of ostrich and chicken cholecystokinin cDNA and intestinal peptides☆ 1 1 ☆ The sequences reported in this paper have been deposited in the EMBL database under the accession nos. AJ251273 (chicken CCK cDNA) and AJ251274 (ostrich CCK cDNA).

A. Johnsen, L. Jønson, R. Naudé, 2000, Peptides.

Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers.

Christiana Kartsonaki, Mads Thomassen, Etienne Rouleau, 2011, Human molecular genetics.

Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers.

F. Couch, B. Karlan, J. Benítez, 2011, Journal of the National Cancer Institute.

Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

W. Chung, P. Hall, V. Pankratz, 2013, PLoS Genetics.

Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers

W. Chung, R. Nussbaum, D. Steinemann, 2015, PloS one.

DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

Olufunmilayo I. Olopade, Mads Thomassen, Torben A. Kruse, 2014, PLoS genetics.

University of Groningen DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers Osorio,

Rensburg, A. Whittemore, D. Steinemann, 2014 .

STAT5 induces miR-21 expression in cutaneous T cell lymphoma

B. Nielsen, D. Sasseville, C. Geisler, 2016, Oncotarget.

STAT5 induces miR-21 expression in cutaneous T cell lymphoma

B. Nielsen, D. Sasseville, C. Geisler, 2016, Oncotarget.

Exome-Based Trio Analysis for Diagnosis of the Cause of Congenital Severe Hemolytic Anemia in a Child

L. Jønson, M. Dziegiel, K. Rieneck, 2022, Transfusion Medicine and Hemotherapy.

STAT5-mediated expression of oncogenic miR-155 in cutaneous T-cell lymphoma

T. Litman, C. Geisler, M. Wasik, 2013, Cell cycle.

Large BRCA1 and BRCA2 genomic rearrangements in Danish high risk breast-ovarian cancer families

Anders Albrechtsen, A. Albrechtsen, T. Hansen, 2009, Breast Cancer Research and Treatment.

Deep targeted sequencing of TP53 in chronic lymphocytic leukemia: clinical impact at diagnosis and at time of treatment

Savvas Kinalis, F. Nielsen, C. Geisler, 2018, Haematologica.

Whole-exome sequencing of a patient with severe and complex hemostatic abnormalities reveals a possible contributing frameshift mutation in C3AR1

Ove Juul Nielsen, M. Rossing, L. Jønson, 2016, Cold Spring Harbor molecular case studies.

Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers

W. Chung, R. Nussbaum, D. Steinemann, 2014, Cancer Epidemiology, Biomarkers & Prevention.

The silent mutation nucleotide 744 G → A, Lys172Lys, in exon 6 of BRCA2 results in exon skipping

T. Hansen, F. Nielsen, M. Andersen, 2010, Breast Cancer Research and Treatment.

Mutations in COA3 cause isolated complex IV deficiency associated with neuropathy, exercise intolerance, obesity, and short stature

E. Shoubridge, Woranontee Weraarpachai, J. Vissing, 2015, Journal of Medical Genetics.

Novel de novo BRCA2 mutation in a patient with a family history of breast cancer

H. Eiberg, A. Albrechtsen, F. Nielsen, 2008, BMC Medical Genetics.

Next-Generation Sequencing-Based Detection of Germline Copy Number Variations in BRCA1/BRCA2: Validation of a One-Step Diagnostic Workflow.

T. Hansen, F. Nielsen, L. Jønson, 2017, The Journal of molecular diagnostics : JMD.

Identification and expression of gastrin and cholecystokinin mRNAs from the turtle, Pseudemys scripta: evidence of tissue-specific tyrosyl sulfation

A. Johnsen, L. Jønson, J. Bundgaard, 1999 .